IMMUNOPRECISE ANTIBODIES LTD (IPA) Dividend History

Company News

• ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates

  ImmunoPrecise Antibodies Ltd. (IPA) delivered earnings and revenue surprises of 0% and 3.93%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research
• Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

  Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expectations of $339.525 million. HighPeak Energy shares declined 15.3% to $13.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud. CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia." Brera Holdings PLC (NASDAQ: BREA) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company. Grom Social Enterprises, Inc. (NASDAQ: GROM) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7. Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120. ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology. Beneficient (NASDAQ: BENF) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital. MoneyLion Inc. (NYSE: ML) gained 28.3% to $67.43 ...

  Benzinga

  Featured Companies: ADT AEYE AISP APM ARHS BENF BREA CC CELZ CERO CIEN CMPO CRBP DAVE EBS EHAB ETWO HDSN HNST HPK KR KRO MEI MNMD OSPN RSI STVN SWIN TPVG VKTX VSCO WVE YEXT YGMZ
• New Strong Buy Stocks for February 7th

  AMSC, META, CLX, IPA and KMPR have been added to the Zacks Rank #1 (Strong Buy) List on February 7, 2023.

  Zacks Investment Research

  Featured Companies: AMSC CLX KMPR META
• New Strong Buy Stocks for February 5th

  EZPW, MOD, IPA, WDC and OSK have been added to the Zacks Rank #1 (Strong Buy) List on February 5, 2023.

  Zacks Investment Research

  Featured Companies: EZPW MOD OSK WDC
• Gold Moves Higher; Campbell Soup Earnings Top Expectations

  U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73. Check This Out: Top 3 Materials Stocks That Are Set To Fly In Q4   Leading and Lagging Sectors   Consumer discretionary shares rose by 0.9% on Wednesday. In trading on Wednesday, energy shares dipped by 1.8%.   Top Headline   Campbell Soup Co (NYSE: CPB) reported better-than-expected first-quarter earnings and reaffirmed FY24 guidance. Campbell Soup reported a first-quarter FY24 sales decline of 2% year-on-year to $2.52 billion, in line with the analyst consensus. Adjusted EPS of $0.91 beat the analyst consensus of $0.88.   Equities Trading UP   Sera Prognostics, Inc. (NASDAQ: SERA) shares shot up 221% to $6.97 after the company announced the DSMB overseeing its PRIME study recommended stopping enrollment due to efficacy. Shares of MicroAlgo Inc. (NASDAQ: MLGO) got a boost, shooting 145% to $5.92 after the company announced it plans to establish a postgraduate training practice base. Pharvaris N.V. (NASDAQ: PHVS) shares were also up, gaining 28% to $26.86 after the company announced the CHAPTER-1 Phase 2 clinical study met its primary ...

  Benzinga

  Featured Companies: CPB MLGO PHVS SERA YEXT